MicroRNA-148b Acts as a Tumor Suppressor in Cervical Cancer by Inducing G1/S-Phase Cell Cycle Arrest and Apoptosis in a Caspase-3-Dependent Manner.

Global cancer statistics, 2012. CA Cancer J Clin (2015) 53.52

Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev (1993) 8.03

MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death. Oncogene (2008) 4.11

MicroRNAs in human cancer. Adv Exp Med Biol (2013) 3.19

microRNA involvement in human cancer. Carcinogenesis (2012) 2.98

MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy. Int J Biochem Cell Biol (2009) 2.86

MicroRNA-21 and microRNA-148a contribute to DNA hypomethylation in lupus CD4+ T cells by directly and indirectly targeting DNA methyltransferase 1. J Immunol (2010) 2.63

Epigenetics in cancer: targeting chromatin modifications. Mol Cancer Ther (2009) 2.50

Altered MicroRNA expression in cervical carcinomas. Clin Cancer Res (2008) 2.42

Control of cell proliferation pathways by microRNAs. Cell Cycle (2008) 2.33

A microRNA expression signature for cervical cancer prognosis. Cancer Res (2010) 2.14

Implications of micro-RNA profiling for cancer diagnosis. Oncogene (2006) 2.01

MicroRNA-148b is frequently down-regulated in gastric cancer and acts as a tumor suppressor by inhibiting cell proliferation. Mol Cancer (2011) 1.89

DNA methylation and microRNA dysregulation in cancer. Mol Oncol (2012) 1.69

Altered expression of MiR-148a and MiR-152 in gastrointestinal cancers and its clinical significance. J Gastrointest Surg (2010) 1.63

Apoptosis in cancer: key molecular signaling pathways and therapy targets. Acta Oncol (2009) 1.34

miR-148b functions as a tumor suppressor in pancreatic cancer by targeting AMPKα1. Mol Cancer Ther (2012) 1.29

Overview of cervical cancer in the developing world. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet (2006) 1.12

Potential of DNMT and its Epigenetic Regulation for Lung Cancer Therapy. Curr Genomics (2009) 1.11

MicroRNA-148b enhances the radiosensitivity of non-Hodgkin's Lymphoma cells by promoting radiation-induced apoptosis. J Radiat Res (2012) 1.09

MicroRNA-140 acts as a liver tumor suppressor by controlling NF-κB activity by directly targeting DNA methyltransferase 1 (Dnmt1) expression. Hepatology (2013) 1.09

Regulation of cancer aggressive features in melanoma cells by microRNAs. PLoS One (2011) 1.07

MicroRNA-182 plays an onco-miRNA role in cervical cancer. Gynecol Oncol (2013) 1.07

Aberrant expression of cyclin D1 is associated with poor prognosis in early stage cervical cancer of the uterus. Gynecol Oncol (2001) 1.05

MicroRNA-148b expression is decreased in hepatocellular carcinoma and associated with prognosis. Med Oncol (2014) 1.05

MicroRNA-148b and microRNA-152 reactivate tumor suppressor genes through suppression of DNA methyltransferase-1 gene in pancreatic cancer cell lines. Cancer Biol Ther (2014) 1.04

DNA methyltransferase-1 inhibitors as epigenetic therapy for cancer. Curr Cancer Drug Targets (2013) 1.03

Effects of DNMT1 silencing on malignant phenotype and methylated gene expression in cervical cancer cells. J Exp Clin Cancer Res (2011) 1.03

Caspases as regulators of apoptosis and other cell functions. Biochemistry (Mosc) (2003) 1.00

MicroRNA-148b is down-regulated in non-small cell lung cancer and associated with poor survival. Int J Clin Exp Pathol (2015) 0.94

MiR-1246 promotes SiHa cervical cancer cell proliferation, invasion, and migration through suppression of its target gene thrombospondin 2. Arch Gynecol Obstet (2014) 0.93

DNA methylation as a target of epigenetic therapeutics in cancer. Anticancer Agents Med Chem (2013) 0.92

Tumor-suppressive microRNA-29a inhibits cancer cell migration and invasion via targeting HSP47 in cervical squamous cell carcinoma. Int J Oncol (2013) 0.92

Altered p53 regulation of miR-148b and p55PIK contributes to tumor progression in colorectal cancer. Oncogene (2014) 0.89

Increased expression of DNA methyltransferase 1 (DNMT1) protein in uterine cervix squamous cell carcinoma and its precursor lesion. Cancer Lett (2006) 0.89

miR-148b reverses cisplatin-resistance in non-small cell cancer cells via negatively regulating DNA (cytosine-5)-methyltransferase 1(DNMT1) expression. J Transl Med (2015) 0.87

Folate deficiency and aberrant expression of DNA methyltransferase 1 were associated with cervical cancerization. Curr Pharm Des (2014) 0.82

MicroRNA-195 inhibits proliferation of cervical cancer cells by targeting cyclin D1a. Tumour Biol (2015) 0.81